Back to Search

ADINE BRANDES, MD

MD

Pediatrics Physician

NPI: 1578649901Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

1662291(NY)

Research & Publications (20)

Adaptive redistribution of NBCe1-A and NBCe1-B in rat kidney proximal tubule and striated ducts of salivary glands during acid-base disturbances.
PMID 17855492·Am J Physiol Regul Integr Comp Physiol·2007
7-preclinical
Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma.
PMID 11859991·Acta Oncol·2001
5-case
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
PMID 10757558·Anticancer Drugs·2000
5-case
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
PMID 19514084·Cancer·2009
8-other
Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
PMID 19521509·PLoS Pathog·2009
7-preclinical
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
PMID 19224764·Neuro Oncol·2009
4-observational
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
PMID 19269895·Lancet Oncol·2009
3-trial
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.
PMID 19188675·J Clin Oncol·2009
8-other
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.
PMID 19204207·J Clin Oncol·2009
3-trial
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
PMID 19169684·Cancer Chemother Pharmacol·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
51 E 25TH ST FL 3
NEW YORK, NY 10010

Quick Facts

NPI
1578649901
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile